Search NASA⌕ Search

SEARCH · Search NASA

Results for “hardware accelerators”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 919 records · Page 51

Upgrade and Operation of the ATLAS Radiation Interlock System (ARIS)

ATLAS (the Argonne Tandem Linac Accelerator Sys-tem) is a superconducting heavy ion accelerator which can accelerate nearly all stable, and some unstable, iso-topes between hydrogen and uranium. Prompt radiation fields from gamma and or neutron are typically below 1 rem/hr at 30 cm, but are permitted up to 300 rem/hr at 30 cm. The original ATLAS Radiation Interlock System (ARIS), hereafter referred to as ARIS 1.0 was installed 30 years ago. While it has been a functional critical safe-ty system, its age has exposed the facility to high risk of temporary shutdown due to failure of obsolete compo-nents. Topics discussed will be architecture, hardware improvements, functional improvements, and operation permitting personnel access to areas with low levels of radiation.

Blomberg, B. R.↗

FY20 ASC IC L2 Milestone 7180: Performance Portability of SIERRA Mechanics Applications to ATS-1 and ATS-2. Executive Summary

The overall goal of this work was to accelerate simulations supporting the nuclear deterrence (ND) mission through improved performance of key algorithms in the ASC IC Sierra multi-physics application suite. This work focused on porting and optimizing algorithms for the graphics processing units (GPU) on the second ASC advanced technology system (ATS-2), while maintaining or improving performance on commodity technology systems (CTS) and ATS-1. Furthermore, these algorithmic developments used the ASC developed Kokkos performance portability abstraction library to maintain high performance across platforms using identical code, and enable sustainable reduced-cost migration and performance optimization to emerging hardware.

97 MATHEMATICS AND COMPUTING↗

GPU/MIC Acceleration of the LHC High Level Trigger to Extend the Physics Reach at the LHC

The quest for rare new physics phenomena leads the PI to propose evaluation of coprocessors based on Graphics Processing Units (GPUs) and the Intel Many Integrated Core (MIC) architecture for integration into the trigger system at LHC. This will require development of a new massively parallel implementation of the well known Combinatorial Track Finder which uses the Kalman Filter to accelerate processing of data from the silicon pixel and microstrip detectors and reconstruct the trajectory of all charged particles down to momentums of 100 MeV. It is expected to run at least one order of magnitude faster than an equivalent algorithm on a quad core CPU for extreme pileup scenarios of 100 interactions per bunch crossing. The new tracking algorithms will be developed and optimized separately on the GPU and Intel MIC and then evaluated against each other for performance and power efficiency. The results will be used to project the cost of the proposed hardware architectures for the HLT server farm, taking into account the long term projections of the main vendors in the market (AMD, Intel, and NVIDIA) over the next 10 years. Extensive experience and familiarity of the PI with the LHC tracker and trigger requirements led to the development of a complementary tracking algorithm that is described in [arxiv: 1305.4855], [arxiv: 1309.6275] and preliminary results accepted to JINST.

97 MATHEMATICS AND COMPUTING↗

A QUEST FOR SYSTEM FRIENDLINESS WITH THE SNS ION BEAM BUNCH SHAPE MONITOR

A new system for measuring the SNS ion beam longitudinal profile was recently upgraded to operational status. The hardware for this device was developed and delivered by Institute of Nuclear Research to the SNS as a part of its initial construction. The supplied LabVIEW user interface software was intended for proof-of-operation and initial setup of the instrument. While satisfactory for this, it was tedious to use in a practical context and lacked any form of interface to the SNS EPICS based control system. This paper will describe the software features added to make this instrument both easily tunable to the prevalent beam conditions by system engineers and easily usable by accelerator physicists only interested in its output data.

43 PARTICLE ACCELERATORS↗

Quantifying Carbon-14 for Biology Using Cavity Ring-Down Spectroscopy

A cavity ring-down spectroscopy (CRDS) instrument was developed using mature, robust hardware for the measurement of carbon-14 in biological studies. The system was characterized using carbon-14 elevated glucose samples and returned a linear response up to 387 times contemporary carbon-14 concentrations. Carbon-14 free and contemporary carbon-14 samples with varying carbon-13 concentrations were used to assess the method detection limit of approximately one-third contemporary carbon-14 levels. Sources of inaccuracies are presented and discussed, and the capability to measure carbon-14 in biological samples is demonstrated by comparing pharmacokinetics from carbon-14 dosed guinea pigs analyzed by both CRDS and accelerator mass spectrometry. Here, the CRDS approach presented affords easy access to powerful carbon-14 tracer techniques that can characterize complex biochemical systems.

07 ISOTOPE AND RADIATION SOURCES↗

High Precision RF Control for SRF Cavities in LCLS-II

The unique properties of SRF cavities enable a new generation of X-ray light sources in XFEL and LCLS-II. The LCLS-II design calls for 280 L-band cavities to be operated in CW mode with a Q_{L} of 4x10⁷, using Single-Source Single-Cavity control. The target RF field stability is 0.01% and 0.01 degree for the band above 1 Hz. Hardware and software implementing a digital LLRF system has been constructed by a four-lab collaboration to minimize known contributors to cavity RF field fluctuation. Efforts include careful attachment to the phase reference line, and minimizing the effects of RF crosstalk by placing forward and reverse signals in chassis separate from the cavity measurement. A low-noise receiver/digitizer section will allow feedback to operate with high proportional gain without excessive noise being sent to the drive amplifier. Test results will show behavior on prototype cryomodules at FNAL and JLab, ahead of the 2018 final accelerator installation.

43 PARTICLE ACCELERATORS↗

A high performance DAC /DDS daughter module for the RHIC LLRF platform

The RHIC LLRF upgrade is a flexible, modular system. Output signals are generated by a custom designed XMC card with 4 high speed digital to analog (DAC) converters interfaced to a high performance field programmable gate array (FPGA). This paper discusses the hardware details of the XMC DAC board as well as the implementation of a low noise rf synthesizer with digital IQ modulation. This synthesizer also provides injection phase cogging and frequency hop rebucketing capabilities. A new modular RHIC LLRF system was recently designed and commissioned based on custom designed XMC cards. As part of that effort a high speed, four channel DAC board was designed. The board uses Maxim MAX5891 16 bit DACs with a maximum update rate of 600 Msps. Since this module is intended to be used for many different systems throughout the Collider Accelerator complex, it was designed to be as generic as possible. One major application of this DAC card is to implement digital synthesizers to provide drive signals to the various cavities at RHIC. Since RHIC is a storage ring with stores that typically last many hours, extremely low RF noise is a critical requirement. Synchrotron frequencies at RHIC range from a few hertz to several hundred hertz depending on the species and point in the acceleration cycle so close in phase noise is a major concern. The RHIC LLRF system uses the Update Link, a deterministic, high speed data link that broadcasts the revolution frequency and the synchronous phase angle. The digital synthesizers use this data to generate a properly phased analog drive signal. The synthesizers must also provide smooth phase shifts for cogging and support frequency shift rebucketing. One additional feature implemented in the FPGA is a digital waveform generator (WFG) that generates I and Q data pairs based on a user selected amplitude and phase profile as a function of time.

43 PARTICLE ACCELERATORS↗

WE-AB-201-00: Treatment Planning System Commissioning and QA

Treatment planning systems (TPS) are a cornerstone of modern radiation therapy. Errors in their commissioning or use can have a devastating impact on many patients. To support safe and high quality care, medical physicists must conduct efficient and proper commissioning, good clinical integration, and ongoing quality assurance (QA) of the TPS. AAPM Task Group 53 and related publications have served as seminal benchmarks for TPS commissioning and QA over the past two decades. Over the same time, continuing innovations have made the TPS even more complex and more central to the clinical process. Medical goals are now expressed in terms of the dose and margins around organs and tissues that are delineated from multiple imaging modalities (CT, MR and PET); and even temporally resolved (i.e., 4D) imaging. This information is passed on to optimization algorithms to establish accelerator movements that are programmed directly for IMRT, VMAT and stereotactic treatments. These advances have made commissioning and QA of the TPS much more challenging. This education session reviews up-to-date experience and guidance on this subject; including the recently published AAPM Medical Physics Practice Guideline (MPPG) #5 “Commissioning and QA of Treatment Planning Dose Calculations: Megavoltage Photon and Electron Beams”. Treatment Planning System Commissioning and QA: Challenges and Opportunities (Greg Salomons) This session will provide some key background and review publications describing prominent incidents relating to TPS commissioning and QA. Traditional approaches have been hardware and feature oriented. They aim to establish a functional configuration and establish specifications for regular testing of features (like dose calculation) to assure stable operation and detect failures. With the advent of more complex systems, more patient-specific testing has also been adopted. A number of actual TPS defects will be presented along with heuristics for identifying similar defects in the future. Finally, the Gamma test has become a popular metric for reporting TPS Commissioning and QA results. It simplifies complex testing into a numerical index, but noisy data and casual application can make it misleading. A brief review of the issues around the use of the Gamma test will be presented. TPS commissioning and QA: A process orientation and application of control charts (Michael Sharpe) A framework for commissioning a treatment planning system will be presented, focusing on preparations, practical aspects of configuration, priorities, specifications, and establishing performance. The complexity of the modern TPS make modular testing of features inadequate, and modern QA tools can provide “too much information” about the performance of techniques like IMRT and VMAT. We have adopted a process orientation and quality tools, like control charts, for ongoing TPS QA and assessment of patient-specific tests. The trending nature of these tools reveals the overall performance of the TPS system, and quantifies the variations that arise from individual plans, discrete calculations, and experimentation based on discrete measurements. Examples demonstrating application of these tools to TPS QA will be presented. TPS commissioning and QA: Incorporating the entire planning process (Sasa Mutic) The TPS and its features do not perform in isolation. Instead, the features and modules are key components in a complex process that begins with CT Simulation and extends to treatment delivery, along with image guidance and verification. Most importantly, the TPS is used by people working in a multi-disciplinary environment. It is very difficult to predict the outcomes of human interactions with software. Therefore, an interdisciplinary approach to training, commissioning and QA will be presented, along with an approach to the physics chart check and end-to-end testing as a tool for TPS QA. The role of standardization and automation in QA will also be discussed. The recommendations of MPPG #5 and practical implementation strategies (Jennifer Smilowitz) The recently published recommendations from Task Group No. 244, Medical Physics Practice Guideline on Commissioning and QA of Treatment Planning Dose Calculations: Megavoltage Photon and Electron Beams will be presented. The recommendations focus on the validation of commissioning data and dose calculations. Tolerance values for non-IMRT beam configurations are summarized based on established criteria and data collected by the IROC. More stringent evaluation criteria for IMRT dose calculations are suggested to test the limitations of the TPS dose algorithms for advanced delivery conditions. The MPPG encourages users to create a suite of validation tests for dose calculation for various conditions for static photon beams, heterogeneities, IMRT/VMAT and electron beams. This test suite is intended to be used for subsequent testing, including TPS software upgrades. In the past, the recommendations of some reports have not been widely implemented due to practical limitations. Implementation strategies, tools and processes developed by multiple centers for efficient and “do-able” MPPG # 5 testing will be presented, as well as a discussion on the overall validation experience. Learning Objectives: Identify some of the key documents relevant for TPS commissioning and QA Understand strategies for testing TPS software Gain a practical knowledge of the Gamma test criteria Increase familiarity with the process of commissioning a TPS Learn about the use of Control Charts for TPS QA Review the role of the TPS in the overall planning process Increase awareness of the link between TPS QA and chart checking Gain an increased appreciation for the importance of interdisciplinary communication Understand the new recommendations from MPPG #5 on TPS Dose Algorithm Commissioning and QC/QA Learn practical implementation processes and tools for MPPG #5 validation recommendations.

60 APPLIED LIFE SCIENCES↗

WE-AB-201-01: Treatment Planning System Commissioning and QA: Challenges and Opportunities

Treatment planning systems (TPS) are a cornerstone of modern radiation therapy. Errors in their commissioning or use can have a devastating impact on many patients. To support safe and high quality care, medical physicists must conduct efficient and proper commissioning, good clinical integration, and ongoing quality assurance (QA) of the TPS. AAPM Task Group 53 and related publications have served as seminal benchmarks for TPS commissioning and QA over the past two decades. Over the same time, continuing innovations have made the TPS even more complex and more central to the clinical process. Medical goals are now expressed in terms of the dose and margins around organs and tissues that are delineated from multiple imaging modalities (CT, MR and PET); and even temporally resolved (i.e., 4D) imaging. This information is passed on to optimization algorithms to establish accelerator movements that are programmed directly for IMRT, VMAT and stereotactic treatments. These advances have made commissioning and QA of the TPS much more challenging. This education session reviews up-to-date experience and guidance on this subject; including the recently published AAPM Medical Physics Practice Guideline (MPPG) #5 “Commissioning and QA of Treatment Planning Dose Calculations: Megavoltage Photon and Electron Beams”. Treatment Planning System Commissioning and QA: Challenges and Opportunities (Greg Salomons) This session will provide some key background and review publications describing prominent incidents relating to TPS commissioning and QA. Traditional approaches have been hardware and feature oriented. They aim to establish a functional configuration and establish specifications for regular testing of features (like dose calculation) to assure stable operation and detect failures. With the advent of more complex systems, more patient-specific testing has also been adopted. A number of actual TPS defects will be presented along with heuristics for identifying similar defects in the future. Finally, the Gamma test has become a popular metric for reporting TPS Commissioning and QA results. It simplifies complex testing into a numerical index, but noisy data and casual application can make it misleading. A brief review of the issues around the use of the Gamma test will be presented. TPS commissioning and QA: A process orientation and application of control charts (Michael Sharpe) A framework for commissioning a treatment planning system will be presented, focusing on preparations, practical aspects of configuration, priorities, specifications, and establishing performance. The complexity of the modern TPS make modular testing of features inadequate, and modern QA tools can provide “too much information” about the performance of techniques like IMRT and VMAT. We have adopted a process orientation and quality tools, like control charts, for ongoing TPS QA and assessment of patient-specific tests. The trending nature of these tools reveals the overall performance of the TPS system, and quantifies the variations that arise from individual plans, discrete calculations, and experimentation based on discrete measurements. Examples demonstrating application of these tools to TPS QA will be presented. TPS commissioning and QA: Incorporating the entire planning process (Sasa Mutic) The TPS and its features do not perform in isolation. Instead, the features and modules are key components in a complex process that begins with CT Simulation and extends to treatment delivery, along with image guidance and verification. Most importantly, the TPS is used by people working in a multi-disciplinary environment. It is very difficult to predict the outcomes of human interactions with software. Therefore, an interdisciplinary approach to training, commissioning and QA will be presented, along with an approach to the physics chart check and end-to-end testing as a tool for TPS QA. The role of standardization and automation in QA will also be discussed. The recommendations of MPPG #5 and practical implementation strategies (Jennifer Smilowitz) The recently published recommendations from Task Group No. 244, Medical Physics Practice Guideline on Commissioning and QA of Treatment Planning Dose Calculations: Megavoltage Photon and Electron Beams will be presented. The recommendations focus on the validation of commissioning data and dose calculations. Tolerance values for non-IMRT beam configurations are summarized based on established criteria and data collected by the IROC. More stringent evaluation criteria for IMRT dose calculations are suggested to test the limitations of the TPS dose algorithms for advanced delivery conditions. The MPPG encourages users to create a suite of validation tests for dose calculation for various conditions for static photon beams, heterogeneities, IMRT/VMAT and electron beams. This test suite is intended to be used for subsequent testing, including TPS software upgrades. In the past, the recommendations of some reports have not been widely implemented due to practical limitations. Implementation strategies, tools and processes developed by multiple centers for efficient and “do-able” MPPG #5 testing will be presented, as well as a discussion on the overall validation experience. Learning Objectives: Identify some of the key documents relevant for TPS commissioning and QA Understand strategies for testing TPS software Gain a practical knowledge of the Gamma test criteria Increase familiarity with the process of commissioning a TPS Learn about the use of Control Charts for TPS QA Review the role of the TPS in the overall planning process Increase awareness of the link between TPS QA and chart checking Gain an increased appreciation for the importance of interdisciplinary communication Understand the new recommendations from MPPG #5 on TPS Dose Algorithm Commissioning and QC/QA Learn practical implementation processes and tools for MPPG #5 validation recommendations.

60 APPLIED LIFE SCIENCES↗

WE-AB-201-02: TPS Commissioning and QA: A Process Orientation and Application of Control Charts

Treatment planning systems (TPS) are a cornerstone of modern radiation therapy. Errors in their commissioning or use can have a devastating impact on many patients. To support safe and high quality care, medical physicists must conduct efficient and proper commissioning, good clinical integration, and ongoing quality assurance (QA) of the TPS. AAPM Task Group 53 and related publications have served as seminal benchmarks for TPS commissioning and QA over the past two decades. Over the same time, continuing innovations have made the TPS even more complex and more central to the clinical process. Medical goals are now expressed in terms of the dose and margins around organs and tissues that are delineated from multiple imaging modalities (CT, MR and PET); and even temporally resolved (i.e., 4D) imaging. This information is passed on to optimization algorithms to establish accelerator movements that are programmed directly for IMRT, VMAT and stereotactic treatments. These advances have made commissioning and QA of the TPS much more challenging. This education session reviews up-to-date experience and guidance on this subject; including the recently published AAPM Medical Physics Practice Guideline (MPPG) #5 “Commissioning and QA of Treatment Planning Dose Calculations: Megavoltage Photon and Electron Beams”. Treatment Planning System Commissioning and QA: Challenges and Opportunities (Greg Salomons) This session will provide some key background and review publications describing prominent incidents relating to TPS commissioning and QA. Traditional approaches have been hardware and feature oriented. They aim to establish a functional configuration and establish specifications for regular testing of features (like dose calculation) to assure stable operation and detect failures. With the advent of more complex systems, more patient-specific testing has also been adopted. A number of actual TPS defects will be presented along with heuristics for identifying similar defects in the future. Finally, the Gamma test has become a popular metric for reporting TPS Commissioning and QA results. It simplifies complex testing into a numerical index, but noisy data and casual application can make it misleading. A brief review of the issues around the use of the Gamma test will be presented. TPS commissioning and QA: A process orientation and application of control charts (Michael Sharpe) A framework for commissioning a treatment planning system will be presented, focusing on preparations, practical aspects of configuration, priorities, specifications, and establishing performance. The complexity of the modern TPS make modular testing of features inadequate, and modern QA tools can provide “too much information” about the performance of techniques like IMRT and VMAT. We have adopted a process orientation and quality tools, like control charts, for ongoing TPS QA and assessment of patient-specific tests. The trending nature of these tools reveals the overall performance of the TPS system, and quantifies the variations that arise from individual plans, discrete calculations, and experimentation based on discrete measurements. Examples demonstrating application of these tools to TPS QA will be presented. TPS commissioning and QA: Incorporating the entire planning process (Sasa Mutic) The TPS and its features do not perform in isolation. Instead, the features and modules are key components in a complex process that begins with CT Simulation and extends to treatment delivery, along with image guidance and verification. Most importantly, the TPS is used by people working in a multi-disciplinary environment. It is very difficult to predict the outcomes of human interactions with software. Therefore, an interdisciplinary approach to training, commissioning and QA will be presented, along with an approach to the physics chart check and end-to-end testing as a tool for TPS QA. The role of standardization and automation in QA will also be discussed. The recommendations of MPPG #5 and practical implementation strategies (Jennifer Smilowitz) The recently published recommendations from Task Group No. 244, Medical Physics Practice Guideline on Commissioning and QA of Treatment Planning Dose Calculations: Megavoltage Photon and Electron Beams will be presented. The recommendations focus on the validation of commissioning data and dose calculations. Tolerance values for non-IMRT beam configurations are summarized based on established criteria and data collected by the IROC. More stringent evaluation criteria for IMRT dose calculations are suggested to test the limitations of the TPS dose algorithms for advanced delivery conditions. The MPPG encourages users to create a suite of validation tests for dose calculation for various conditions for static photon beams, heterogeneities, IMRT/VMAT and electron beams. This test suite is intended to be used for subsequent testing, including TPS software upgrades. In the past, the recommendations of some reports have not been widely implemented due to practical limitations. Implementation strategies, tools and processes developed by multiple centers for efficient and “do-able” MPPG #5 testing will be presented, as well as a discussion on the overall validation experience. Learning Objectives: Identify some of the key documents relevant for TPS commissioning and QA Understand strategies for testing TPS software Gain a practical knowledge of the Gamma test criteria Increase familiarity with the process of commissioning a TPS Learn about the use of Control Charts for TPS QA Review the role of the TPS in the overall planning process Increase awareness of the link between TPS QA and chart checking Gain an increased appreciation for the importance of interdisciplinary communication Understand the new recommendations from MPPG #5 on TPS Dose Algorithm Commissioning and QC/QA Learn practical implementation processes and tools for MPPG #5 validation recommendations.

60 APPLIED LIFE SCIENCES↗

WE-AB-201-03: TPS Commissioning and QA: Incorporating the Entire Planning Process

Treatment planning systems (TPS) are a cornerstone of modern radiation therapy. Errors in their commissioning or use can have a devastating impact on many patients. To support safe and high quality care, medical physicists must conduct efficient and proper commissioning, good clinical integration, and ongoing quality assurance (QA) of the TPS. AAPM Task Group 53 and related publications have served as seminal benchmarks for TPS commissioning and QA over the past two decades. Over the same time, continuing innovations have made the TPS even more complex and more central to the clinical process. Medical goals are now expressed in terms of the dose and margins around organs and tissues that are delineated from multiple imaging modalities (CT, MR and PET); and even temporally resolved (i.e., 4D) imaging. This information is passed on to optimization algorithms to establish accelerator movements that are programmed directly for IMRT, VMAT and stereotactic treatments. These advances have made commissioning and QA of the TPS much more challenging. This education session reviews up-to-date experience and guidance on this subject; including the recently published AAPM Medical Physics Practice Guideline (MPPG) #5 “Commissioning and QA of Treatment Planning Dose Calculations: Megavoltage Photon and Electron Beams”. Treatment Planning System Commissioning and QA: Challenges and Opportunities (Greg Salomons) This session will provide some key background and review publications describing prominent incidents relating to TPS commissioning and QA. Traditional approaches have been hardware and feature oriented. They aim to establish a functional configuration and establish specifications for regular testing of features (like dose calculation) to assure stable operation and detect failures. With the advent of more complex systems, more patient-specific testing has also been adopted. A number of actual TPS defects will be presented along with heuristics for identifying similar defects in the future. Finally, the Gamma test has become a popular metric for reporting TPS Commissioning and QA results. It simplifies complex testing into a numerical index, but noisy data and casual application can make it misleading. A brief review of the issues around the use of the Gamma test will be presented. TPS commissioning and QA: A process orientation and application of control charts (Michael Sharpe) A framework for commissioning a treatment planning system will be presented, focusing on preparations, practical aspects of configuration, priorities, specifications, and establishing performance. The complexity of the modern TPS make modular testing of features inadequate, and modern QA tools can provide “too much information” about the performance of techniques like IMRT and VMAT. We have adopted a process orientation and quality tools, like control charts, for ongoing TPS QA and assessment of patient-specific tests. The trending nature of these tools reveals the overall performance of the TPS system, and quantifies the variations that arise from individual plans, discrete calculations, and experimentation based on discrete measurements. Examples demonstrating application of these tools to TPS QA will be presented. TPS commissioning and QA: Incorporating the entire planning process (Sasa Mutic) The TPS and its features do not perform in isolation. Instead, the features and modules are key components in a complex process that begins with CT Simulation and extends to treatment delivery, along with image guidance and verification. Most importantly, the TPS is used by people working in a multi-disciplinary environment. It is very difficult to predict the outcomes of human interactions with software. Therefore, an interdisciplinary approach to training, commissioning and QA will be presented, along with an approach to the physics chart check and end-to-end testing as a tool for TPS QA. The role of standardization and automation in QA will also be discussed. The recommendations of MPPG #5 and practical implementation strategies (Jennifer Smilowitz) The recently published recommendations from Task Group No. 244, Medical Physics Practice Guideline on Commissioning and QA of Treatment Planning Dose Calculations: Megavoltage Photon and Electron Beams will be presented. The recommendations focus on the validation of commissioning data and dose calculations. Tolerance values for non-IMRT beam configurations are summarized based on established criteria and data collected by the IROC. More stringent evaluation criteria for IMRT dose calculations are suggested to test the limitations of the TPS dose algorithms for advanced delivery conditions. The MPPG encourages users to create a suite of validation tests for dose calculation for various conditions for static photon beams, heterogeneities, IMRT/VMAT and electron beams. This test suite is intended to be used for subsequent testing, including TPS software upgrades. In the past, the recommendations of some reports have not been widely implemented due to practical limitations. Implementation strategies, tools and processes developed by multiple centers for efficient and “do-able” MPPG #5 testing will be presented, as well as a discussion on the overall validation experience. Learning Objectives: Identify some of the key documents relevant for TPS commissioning and QA Understand strategies for testing TPS software Gain a practical knowledge of the Gamma test criteria Increase familiarity with the process of commissioning a TPS Learn about the use of Control Charts for TPS QA Review the role of the TPS in the overall planning process Increase awareness of the link between TPS QA and chart checking Gain an increased appreciation for the importance of interdisciplinary communication Understand the new recommendations from MPPG #5 on TPS Dose Algorithm Commissioning and QC/QA Learn practical implementation processes and tools for MPPG #5 validation recommendations.

60 APPLIED LIFE SCIENCES↗

WE-AB-201-04: The Recommendations of MPPG #5 and Practical Implementation Strategies

Treatment planning systems (TPS) are a cornerstone of modern radiation therapy. Errors in their commissioning or use can have a devastating impact on many patients. To support safe and high quality care, medical physicists must conduct efficient and proper commissioning, good clinical integration, and ongoing quality assurance (QA) of the TPS. AAPM Task Group 53 and related publications have served as seminal benchmarks for TPS commissioning and QA over the past two decades. Over the same time, continuing innovations have made the TPS even more complex and more central to the clinical process. Medical goals are now expressed in terms of the dose and margins around organs and tissues that are delineated from multiple imaging modalities (CT, MR and PET); and even temporally resolved (i.e., 4D) imaging. This information is passed on to optimization algorithms to establish accelerator movements that are programmed directly for IMRT, VMAT and stereotactic treatments. These advances have made commissioning and QA of the TPS much more challenging. This education session reviews up-to-date experience and guidance on this subject; including the recently published AAPM Medical Physics Practice Guideline (MPPG) #5 “Commissioning and QA of Treatment Planning Dose Calculations: Megavoltage Photon and Electron Beams”. Treatment Planning System Commissioning and QA: Challenges and Opportunities (Greg Salomons) This session will provide some key background and review publications describing prominent incidents relating to TPS commissioning and QA. Traditional approaches have been hardware and feature oriented. They aim to establish a functional configuration and establish specifications for regular testing of features (like dose calculation) to assure stable operation and detect failures. With the advent of more complex systems, more patient-specific testing has also been adopted. A number of actual TPS defects will be presented along with heuristics for identifying similar defects in the future. Finally, the Gamma test has become a popular metric for reporting TPS Commissioning and QA results. It simplifies complex testing into a numerical index, but noisy data and casual application can make it misleading. A brief review of the issues around the use of the Gamma test will be presented. TPS commissioning and QA: A process orientation and application of control charts (Michael Sharpe) A framework for commissioning a treatment planning system will be presented, focusing on preparations, practical aspects of configuration, priorities, specifications, and establishing performance. The complexity of the modern TPS make modular testing of features inadequate, and modern QA tools can provide “too much information” about the performance of techniques like IMRT and VMAT. We have adopted a process orientation and quality tools, like control charts, for ongoing TPS QA and assessment of patient-specific tests. The trending nature of these tools reveals the overall performance of the TPS system, and quantifies the variations that arise from individual plans, discrete calculations, and experimentation based on discrete measurements. Examples demonstrating application of these tools to TPS QA will be presented. TPS commissioning and QA: Incorporating the entire planning process (Sasa Mutic) The TPS and its features do not perform in isolation. Instead, the features and modules are key components in a complex process that begins with CT Simulation and extends to treatment delivery, along with image guidance and verification. Most importantly, the TPS is used by people working in a multi-disciplinary environment. It is very difficult to predict the outcomes of human interactions with software. Therefore, an interdisciplinary approach to training, commissioning and QA will be presented, along with an approach to the physics chart check and end-to-end testing as a tool for TPS QA. The role of standardization and automation in QA will also be discussed. The recommendations of MPPG #5 and practical implementation strategies (Jennifer Smilowitz) The recently published recommendations from Task Group No. 244, Medical Physics Practice Guideline on Commissioning and QA of Treatment Planning Dose Calculations: Megavoltage Photon and Electron Beams will be presented. The recommendations focus on the validation of commissioning data and dose calculations. Tolerance values for non-IMRT beam configurations are summarized based on established criteria and data collected by the IROC. More stringent evaluation criteria for IMRT dose calculations are suggested to test the limitations of the TPS dose algorithms for advanced delivery conditions. The MPPG encourages users to create a suite of validation tests for dose calculation for various conditions for static photon beams, heterogeneities, IMRT/VMAT and electron beams. This test suite is intended to be used for subsequent testing, including TPS software upgrades. In the past, the recommendations of some reports have not been widely implemented due to practical limitations. Implementation strategies, tools and processes developed by multiple centers for efficient and “do-able” MPPG #5 testing will be presented, as well as a discussion on the overall validation experience. Learning Objectives: Identify some of the key documents relevant for TPS commissioning and QA Understand strategies for testing TPS software Gain a practical knowledge of the Gamma test criteria Increase familiarity with the process of commissioning a TPS Learn about the use of Control Charts for TPS QA Review the role of the TPS in the overall planning process Increase awareness of the link between TPS QA and chart checking Gain an increased appreciation for the importance of interdisciplinary communication Understand the new recommendations from MPPG #5 on TPS Dose Algorithm Commissioning and QC/QA Learn practical implementation processes and tools for MPPG #5 validation recommendations.

60 APPLIED LIFE SCIENCES↗

Modeling for the phased injector upgrade for 12 GeV CEBAF

As a follow on to the 12 GeV upgrade to the Continuous Electron Beam Accelerator Facility, the front end of the DC photo-gun-based injector has gone through a phased upgrade. The first phase focused on the beamline between the gun and the RF chopper system, and the second phase addresses the beamline after the RF chopper system including replacing the capture section and quarter cryomodule with a new booster module containing a 2-cell and 7-cell cavity string. Throughout the design process, we maintained and developed three models, one for the existing injector and one for each of the upgrade phases. With these models, we evaluated proposed hardware upgrades, evaluated and determined optimized beamline element positions, developed buncher voltage requirements, and settings for optimal injector running. In this paper, we will describe the models and results from these various studies and provide a brief summary of Phase 1 commissioning.

Kazimi, R.↗

Integrated Multiple Effects Software for Nuclear Physics Applications

The technical progress made during this project has been very substantial, and in most ways has exceeded the expectations of what was intended. In particular, the ability to treat CAD-based complex geometry, using the cut-cell finite-difference methodology, has been evolved to a very advanced state. Figure 1 illustrates the progress made, comparing what the modeling was capable of at the end of the Phase I project, to what it is capable of at the end of the Phase II project. This project had a strong component of collaborative research with activities at the TJNAF (JLab), including scientific assessment of specific nuclear physics hardware, and this collaboration was a main focus during the much of the Phase II project. During the final year of this project, and subsequent months since its completion, the Department of Energy has strongly shifted emphasis for SBIR projects towards commercialization. During this same time frame the software used for the modeling, Vorpal, underwent a similarly dramatic shift from a single product with any-and-all-phyiscs-in-one, to a suite of products, under the name Vsim, with each product individually targeted at one of the areas of: Electromagnetics, Microwave Devices, Plasma Devices, and Accelerator Physics. The focus area of this project, thermal analysis, was a new but important type of multi-physics application for the software involved, and the manner in which it has been implemented is of sufficient generality, that it continues life as a fifth target area, Thermal Transport. Thus, while a somewhat more subtle commercial deployment of this project’s developments was the original intention (e.g., more-physics-in-the-one), the result is in fact more in line with the newer emphasis, e.g., a direct and obvious one-to-one commercial product deployment of project capabilities.

Smithe, David↗

Integrated Multiple Effects Software for Nuclear Physics Applications, Final Report, Phase II SBIR

The technical progress made during this project has been very substantial, and in most ways has exceeded the expectations of what was intended. In particular, the ability to treat CAD-based complex geometry, using the cut-cell finite-difference methodology, has been evolved to a very advanced state. Figure 1 illustrates the progress made, comparing what the modeling was capable of at the end of the Phase I project, to what it is capable of at the end of the Phase II project. This project had a strong component of collaborative research with activities at the TJNAF (JLab), including scientific assessment of specific nuclear physics hardware, and this collaboration was a main focus during the much of the Phase II project. During the final year of this project, and subsequent months since its completion, the Department of Energy has strongly shifted emphasis for SBIR projects towards commercialization. During this same time frame the software used for the modeling, Vorpal, underwent a similarly dramatic shift from a single product with any-and-all-phyiscs-in-one, to a suite of products, under the name Vsim, with each product individually targeted at one of the areas of: Electromagnetics, Microwave Devices, Plasma Devices, and Accelerator Physics. The focus area of this project, thermal analysis, was a new but important type of multi-physics application for the software involved, and the manner in which it has been implemented is of sufficient generality, that it continues life as a fifth target area, Thermal Transport. Thus, while a somewhat more subtle commercial deployment of this project’s developments was the original intention (e.g., more-physics-in-the-one), the result is in fact more in line with the newer emphasis, e.g., a direct and obvious one-to-one commercial product deployment of project capabilities.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

Accelerating End-to-End Deep Learning for Particle Reconstruction using CMS open data

Machine learning algorithms are gaining ground in high energy physics for applications in particle and event identification, physics analysis, detector reconstruction, simulation and trigger. Currently, most data-analysis tasks at LHC experiments benefit from the use of machine learning. Incorporating these computational tools in the experimental framework presents new challenges. This paper reports on the implementation of the end-to-end deep learning with the CMS software framework and the scaling of the end-to-end deep learning with multiple GPUs. The end-to-end deep learning technique combines deep learning algorithms and low-level detector representation for particle and event identification. We demonstrate the end-to-end implementation on a top quark benchmark and perform studies with various hardware architectures including single and multiple GPUs and Google TPU.

72 PHYSICS OF ELEMENTARY PARTICLES AND FIELDS↗

Replacing The Engine In Your Car While You Are Still Driving It [PowerPoint]

The scope of the project included the following: install new network backbone, replace 201 MHz rf tubes, replace low-level rf system, replace timing system, replace industrial I/O system, replace beam synchronous data acquisition system, replace fast protect reporting system, new wire scanner hardware, and new beam position/phase monitor hardware--all of this to be done while continuing to deliver beam to users. Lessons learned, for anyone contemplating a similarly ambitious upgrade: You can’t replace the whole system at once. Some compatibility must be maintained between the old and new systems. Always have a way to fall back. Have sympathy for the operations staff. You will be surprised.

43 PARTICLE ACCELERATORS↗

Optimization and Portability of a Fusion OpenACC-based FORTRAN HPC Code from NVIDIA to AMD GPUs

NVIDIA has been the main provider of GPU hardware in HPC systems for over a decade. Most applications that benefit from GPUs have thus been developed and optimized for the NVIDIA software stack. Recent exascale HPC systems are, however, introducing GPUs from other vendors, e.g. with the AMD GPU-based OLCF Frontier system just becoming available. AMD GPUs cannot be directly accessed using the NVIDIA software stack, and require a porting effort by the application developers. This paper provides an overview of our experience porting and optimizing the CGYRO code, a widely-used fusion simulation tool based on FORTRAN with OpenACC-based GPU acceleration. While the porting from the NVIDIA compilers was relatively straightforward using the CRAY compilers on the AMD systems, the performance optimization required more fine-tuning. In the optimization effort, we uncovered code sections that had performed well on NVIDIA GPUs, but were unexpectedly slow on AMD GPUs. After AMD-targeted code optimizations, performance on AMD GPUs has increased to meet our expectations. Modest speed improvements were also seen on NVIDIA GPUs, which was an unexpected benefit of this exercise.

Sfiligoi, Igor↗